Optimization of the Targeted Anticancer Therapies

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Switzerland

CHUV, Lausanne, Canton of Vaud

Sponsor

Centre Hospitalier Universitaire Vaudois

Collaborators

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland, Krebsforschung Schweiz, Bern, Switzerland

Enrollment target

~500 participants

Started

May 2015

Primary completion

December 2020

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated July 2020